Qiagen NV (QGEN) EPS Estimated At $0.32

October 13, 2017 - By reb123z

 Qiagen NV (QGEN) EPS Estimated At $0.32

Analysts expect Qiagen NV (NASDAQ:QGEN) to report $0.32 EPS on November, 1.They anticipate $0.02 EPS change or 6.67 % from last quarter’s $0.3 EPS. QGEN’s profit would be $73.80M giving it 27.10 P/E if the $0.32 EPS is correct. After having $0.30 EPS previously, Qiagen NV’s analysts see 6.67 % EPS growth. About 1.85 million shares traded or 20.13% up from the average. Qiagen NV (NASDAQ:QGEN) has risen 54.62% since October 13, 2016 and is uptrending. It has outperformed by 37.92% the S&P500.

Qiagen NV (NASDAQ:QGEN) Ratings Coverage

Among 13 analysts covering Qiagen (NASDAQ:QGEN), 4 have Buy rating, 0 Sell and 9 Hold. Therefore 31% are positive. Qiagen had 21 analyst reports since August 3, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Wednesday, September 13 by Jefferies. The rating was maintained by Citigroup on Tuesday, March 15 with “Neutral”. The stock of Qiagen NV (NASDAQ:QGEN) has “Overweight” rating given on Tuesday, September 15 by Morgan Stanley. The firm earned “Hold” rating on Wednesday, September 27 by Cowen & Co. On Tuesday, August 1 the stock rating was upgraded by Independent Research to “Hold”. As per Monday, August 14, the company rating was maintained by Cowen & Co. The rating was initiated by Stifel Nicolaus on Thursday, November 12 with “Hold”. Mizuho maintained Qiagen NV (NASDAQ:QGEN) rating on Thursday, July 30. Mizuho has “Neutral” rating and $25 target. On Monday, June 5 the stock rating was maintained by Jefferies with “Hold”. Piper Jaffray maintained the stock with “Hold” rating in Friday, July 28 report.

QIAGEN N.V. is a holding company. The company has market cap of $8.00 billion. The Firm is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. It has a 105.62 P/E ratio. The Company’s Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems.

Another recent and important Qiagen NV (NASDAQ:QGEN) news was published by Investorplace.com which published an article titled: “Qiagen NV (QGEN) Hold Recommendation Confirmed” on October 05, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.